dehydrogenase

Some holoenzymes, such as pyruvate dehydrogenase, are highly compex, with several cofactors.

有一些全酶是高度复杂的，如丙酮酸脱氢酶。

Intracellular PHB depolymerase and 3 hydroxybutyrate dehydrogenase catalyze the initial reactions of intracellular PHB catabolism.

进一步比较研究了不同菌株的PHB解聚酶和3羟基丁酸脱氢酶的活性。

Aldehyde dehydrogenase is a kind of endoenzyme,and cell disruption is the major step in its extraction from Saccharomyces ceravisia.

乙醛脱氢酶(ALDH)是一种胞内酶,在从酵母分离提取ALDH的过程,破碎细胞是其的关键步骤之一。

The (6). glucose - 6- phosphoric acid dehydrogenase lacks the patient to take this, extremely individual possibly has the hematolysis response.

（6）．葡萄糖-6-磷酸脱氢酶缺乏患者服用本品，极个别可能发生溶血反应。

Recently, it has been shown that the Mitochondrial aldehyde dehydrogenase is responsible for the bioactivation of nitroglycerin prior to the release of NO, which is a strong vasodilator.

近来，有研究表明线粒体乙醛脱氢酶是体内催化硝酸甘油生物转化的主要途径，线粒体乙醛脱氢酶同有脱氢酶和酯酶的催化活性，其酯酶活性可以通过将硝酸甘油脱硝形成一氧化氮，进而血管扩张。

The short-chain Dehydrogenases/Reductases(SDR）family is a very large family of enzymes, most of which are known to be NAD+- or NADP+-dependent oxidoreductases.

短链脱氢酶/还原酶（Short-chain Dehydrogenases/Reductases，SDR）家族是一个由很多成员组成的大家族，其大部分是NAD+或NADP+依赖的氧化还原酶。

Lactococcal lactate dehydrogenases (LDHs) are coregulated at the substrate level by at least two mechanisms: the fructose-1,6-biphosphate/phosphate ratio and the NADH/NAD ratio.

Lactococcal乳酸脱氢酶（滑石）是力的底物水平至少两个机制：果糖-1,6 - biphosphate /磷比值和辅酶/ NAD的比率。

GABA is metabolized by the successive action of GABA transaminase (GABA-T) and succinic semialdehyde dehydrogenase (SSADH), to succinic acid, which is a substrate for the tricarboxylic acid cycle.

GABA的降解主要由GABA转氨酶(GABA-T)催化,脱氨基生成琥珀酸半醛,再经琥珀酸半醛脱氢酶(SSADH)催化生成琥珀酸,进入三羧酸循环。

GABA的降解主要由GABA转氨酶(GABA-T)催化,脱氨基生成琥珀酸半醛,再经琥珀酸半醛脱氢酶(SSADH)催化生成琥珀酸,进入三羧酸循环。

GABA is metabolized by the successive action of GABA transaminase (GABA-T) and succinic semialdehyde dehydrogenase (SSADH), to succinic acid, which is a substrate for the tricarboxylic acid cycle.

Pretesting is recommended because patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency may develop "severe hemolysis" when taking this drug, the FDA table notes.

FDA的表格指出，建议治疗前检测，因为葡萄糖-六-磷酸盐去氢酶(G6PD)缺乏患者服用此药会发生严重的溶血；

Moreover, the activities of isocitrate lyase and isocitrate dehydrogenase in the 0 P-treated cells were 1.48 and 0.75 times higher than in the control at day 8 of the treatment.

在第8 d，缺磷条件下的细胞异柠檬酸裂解酶活性和异柠檬酸脱氢酶活性分别是对照的1.48倍和75%。